Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–40 of 40 results
Advanced filters: Author: Lauren Gravitz Clear advanced filters

  • Breakthrough therapies, new diagnostics and preventive measures for fighting a devastating disease.

    • Lauren Gravitz
    Special Features
    Nature
    Volume: 645, P: S2

  • The idea of using bacteria-fighting viruses as a weapon against hard-to-treat infections is making a surprising comeback, but with a twist on how it has been attempted for nearly a century. Researchers and companies are now tweaking and deconstructing these bacteria killers in an effort to develop a new arsenal against antibiotic-resistant superbugs—one with more potency and a better likelihood of regulatory approval. Lauren Gravitz reports.

    • Lauren Gravitz
    News
    Nature Medicine
    Volume: 18, P: 1318-1320

  • Various approaches are approved for treating blood cancers and a few rare disorders—they may soon become standard care.

    • Lauren Gravitz
    Special Features
    Nature

  • A special package explores problems and solutions to the geography of injustice.

    • Lauren Gravitz
    Special Features
    Nature
    Volume: 621, P: S24

  • As a multifaceted organ, skin provides the body with protection from infection and the environment, as well as sensory capabilities.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 563, P: S83

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 516, P: S1

    • Lauren Gravitz
    • Stephen Pincock
    Comments & Opinion
    Nature
    Volume: 515, P: S1

  • Some researchers are finding clues that MDMA might be able to treat post-traumatic stress disorder. But the science has yet to catch up with the optimism.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 609, P: S83-S85

  • When a transplant is out of reach, kidney failure leaves those without access to high-quality health care with few options.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 615, P: S6-S7

  • By bootstrapping existing technologies, researchers can gain a minute-by-minute understanding of a patient's disease.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 538, P: S8-S10

  • There is little question that supplemental fluoride strengthens teeth and reduces decay. But at what cost?

    • Lauren Gravitz
    Comments & Opinion
    Nature

  • To help solve the opioid epidemic, researchers must understand what makes dependence on these drugs so deadly.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 573, P: S20-S21

  • Identifying the patients most likely to progress from a precancerous condition to multiple myeloma could help doctors catch the disease early and stop it taking hold.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 480, P: S36-S37

  • Plagued by a history of fear and stigma, epilepsy has languished when it comes to research funding.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 511, P: S10-S11

  • Long overshadowed by HIV, the hepatitis C virus is starting to take its toll. And the heat is on to find and treat those affected.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 474, P: S2-S4

  • Your gut microflora might be aiding and abetting diabetes.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 485, P: S12-S13

  • Researchers have plenty of theories about what might cause multiple sclerosis. But for now, the factor that triggers the disease remains elusive.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 484, P: S2

  • Drugs, lifestyle changes and other measures might lower the risk of colorectal cancer — but the evidence is a long time coming.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 521, P: S6-S8

  • Scientists and psychologists are trying to trick our mouths and minds into enjoying foods that are better for us.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 486, P: S14-S15

  • A plethora of therapies can keep the symptoms of allergy under control, but they can't cure. New research aims to prevent allergies from developing in the first place.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 479, P: S17-S19

  • The many levels of bee behaviour offer insights on everything from population dynamics to molecular changes.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 521, P: S60-S61

  • Preventing mosquitoes from transmitting the malaria parasite is a crucial piece of the eradication puzzle.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 484, P: S26-S27

  • Long thought to be a glitch of memory, researchers are coming to realize that the ability to forget is crucial to how the brain works.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 571, P: S12-S14

  • Combinations of drugs are showing some promise as therapeutic agents that stop cancer before it starts.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 471, P: S5-S7

  • Drugs in development for Alzheimer's disease take aim at a variety of neural mechanisms. But despite a wealth of possibilities, there have been few successes.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 475, P: S9-S11

  • Tailoring cancer treatment to individual and evolving tumours is the way of the future, but scientists are still hashing out the details.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 509, P: S52-S54

  • This collection shows what works to advance health equity around the world.

    • Lauren Gravitz
    Special Features
    Nature
    Volume: 634, P: S26

  • The first clinical results in patients with a genetic form of frontotemporal dementia (FTD) show that enhancing progranulin in the brain may halt disease progression. If successful, this potentially disease-modifying approach may uncover new avenues for treating other neurodegenerative diseases.

    • Lauren Gravitz
    News
    Nature Biotechnology
    Volume: 43, P: 151-153

  • Multidirectional imaging of embryos allows researchers to track development of fruitflies in real time.

    • Lauren Gravitz
    News
    Nature

  • Nobel-prizewinner Ralph Steinman tried to beat his cancer with vaccines based on the dendritic cells he discovered.

    • Lauren Gravitz
    News
    Nature
    Volume: 478, P: 163-164

  • Human serum albumin from transgenic rice could ease shortages of donated blood.

    • Lauren Gravitz
    News
    Nature

  • There is only one industrialized country where the rate of maternal deaths has risen over the past 30 years. US researchers are trying to find out what went wrong.

    • Lauren Gravitz
    Comments & Opinion
    Nature
    Volume: 550, P: S20-S23